Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2³ factorial design and in vivo evaluation in rabbits

Reference

• Abdel Malak NS. (2012). Formulation of coated polymer reinforced gellan gum beads of tizanidine HCl using fractional factorial design. Int J Pharm Pharm Sci 4:369–79
   Google Scholar
• Abd-Elbary A, El-Laithy HM, Tadros MI. (2008). Sucrose stearate-basedproniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357:189–98
   PubMed Web of Science ®Google Scholar
• Abdelbary G. (2011). Ocular ciprofloxacin hydrochloride mucoadhesive chitosancoated liposomes. Pharm Dev Technol 16:44–56
   PubMed Web of Science ®Google Scholar
• Aboelwafa AA, El-Setouhy DA, Elmeshad AN. (2010). Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS PharmSciTech 11:1591–602
   PubMed Web of Science ®Google Scholar
• Aburahma MH, Abdelbary GA. (2012). Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm 422:139–50
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. (2012). Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Colloids Surf B: Biointerfaces 100:146–54
   PubMed Web of Science ®Google Scholar
• Ahmed S, El-Setouhy DA, Badawi AA, El-Nabarawi MA. (2014). Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance. Eur J Pharm Sci 60:10–23
   PubMed Web of Science ®Google Scholar
• Akhtara M, Imamb SS, Ahmada MA, et al. (2014). Neuroprotective study of Nigella sativa-loaded oral provesicular lipid formulation: in vitro and ex vivo study. Drug Deliv 21:487–94
   PubMed Web of Science ®Google Scholar
• Ali MH, Kirby DJ, Mohammed AR, Perrie Y. (2010). Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent. J Pharm Pharmacol 62:1646–55
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Asija R, Sharma D, Nirmal H. (2014). Proniosomes: a review. Int J Curr Trends Pharm Res 2:337–41
   Google Scholar
• Azeem IA, Ahmad FJ, Khar RK, Talegaonkar S. (2009). Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech 10:1093–103
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
   PubMed Web of Science ®Google Scholar
• Biju SS. (2006). Vesicular systems: an overview. Ind J Pharm Sci 68:141–53
   Google Scholar
• Chavan P, Jain B, Jain P. (2012). Proniosomal gel: a novel approach for transdermal drug delivery: a review. Int J Pharm Res Dev 4:158–70
   Google Scholar
• Csoka G, Marton S, Zelko R, et al. (2007). Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 65:233–7
   PubMed Web of Science ®Google Scholar
• Draize J, Woodward G, Calvery H. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–9
   Web of Science ®Google Scholar
• Elhissi A, Hidayat K, David A, et al. (2013). Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm 444:193–9
   PubMed Web of Science ®Google Scholar
• ElKasabgy NA, Elsayed I, Elshafeey AH. (2014). Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in-vitro and in-vivo characterization. Int J Pharm 472:369–79
   PubMed Web of Science ®Google Scholar
• El-laithy HM, Shoukry O, Mahran IG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Bendas ER, El Rehem RTA, Abary MYS. (2013). Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm 443:307–17
   PubMed Web of Science ®Google Scholar
• Essa E. (2010). Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm 4:227–33
   Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA. (2013). Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm 453:569–78
   PubMed Web of Science ®Google Scholar
• Gadekar V, Bhowmick M, Pandey GK, et al. (2013). Formulation and evaluation of naproxen proniosomal gel for the treatment of inflammatory and degenerative disorders of the musculoskeletal system. J Drug Deliv Ther 3:36–41
   Google Scholar
• Gannu R, Palem CR, Yamsani VV, et al. (2010). Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm 388:231–41
   PubMed Web of Science ®Google Scholar
• Gannu R, Yamsani VV, Palem CR, et al. (2009). Development of high performance liquid chromatography method for lacidipine in rabbit serum: application to pharmacokinetic study. Anal Chim Acta 632:278–83
   PubMed Web of Science ®Google Scholar
• Grove M, Müllertz A. (2007). Liquid self-microemulsifying drug delivery systems. In oral lipid-based formulations. In: Hauss DJ, ed. New York: Informa Inc., 107–27
   Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
   PubMed Web of Science ®Google Scholar
• Gupta A, Prajapati SK, Balamurugan M, et al. (2007). Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6:687–93
   Web of Science ®Google Scholar
• Hao Y, Zhao L, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Hao YM, Li K. (2011). Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm 403:245–53
   PubMed Web of Science ®Google Scholar
• Hernàndez JRV, Goymann CCM. (2005). Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media. Eur J Pharm Biopharm 60:113–22
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. (2009). Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm 380:96–104
   PubMed Web of Science ®Google Scholar
• Hosny KM. (2010). Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech 11:241–6
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Velpula A, et al. (2012). Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm 80:347–57
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Teeranachaideekul V, Supaperm T. (2008). Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech 9:851–9
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S. (2014). Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Sci World J 2014:959741
   Web of Science ®Google Scholar
• Kantarci G, Ozgungey I, Karasulu HY, et al. (2005). In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin. Drug Dev Res 65:17–25
   Web of Science ®Google Scholar
• Kumar R, Singh B, Bakshi G, Katare OP. (2007). Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm Dev Technol 12:591–601
   PubMed Web of Science ®Google Scholar
• Kumar S, Prajapati S, Sahu VK, Andprakash G. (2012). Proniosomal gel of flurbiprofen: formulation and evaluation. J Drug Deliv Ther 2:1–5
   Google Scholar
• Lee CR, Bryson HM. (1994). Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 48:274–96
   PubMed Web of Science ®Google Scholar
• Mahale NB, Thakkar PD, Mali RG, et al. (2012). Niosomes: novel sustained release nonionic stable vesicular systems: an overview. Adv Colloid Interface Sci 183:46–54
   PubMed Web of Science ®Google Scholar
• Marwa A, Omaima S, Hanaa E, Mohammed A. (2013). Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res 4:1757–65
   Google Scholar
• Mc Cormack PL, Wagstaff AJ. (2003). Lacidipine: a review of its use in the management of hypertension. Drugs 63:2327–56
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Negi P, Ahmad FJ, Ahmad D, et al. (2011). Development of a novel formulation for transdermal delivery of an antidepressant drug. Int J Pharm Sci Res 2:1766–71
   Google Scholar
• Pankaj S, Rini T, Dandagi PM. (2013). Formulation and evaluation of proniosome based drug delivery system of the antifungal drug clotrimazole. Int J Pharm Sci Nanotechnol 6:1945–51
   Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Patil HN, Hardikar SR, Bhosale AV. (2012). Formulation development and evaluation of proniosomal gel of carvedilol. Int J Pharm Pharm Sci 4:191–7
   Google Scholar
• Park ES, Chang SY, Hahn M, Chi SC. (2000). Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm 209:109–19
   PubMed Web of Science ®Google Scholar
• Rahman SA, Abdelmalak NS, Badawi A, et al. (2014). Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv 1–9
   Google Scholar
• Rajabalaya R, David SR, Chellian J, et al. (2015). Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder. Drug Deliv 1–10
   PubMed Web of Science ®Google Scholar
• Ramkanth S, Chetty CM, Sudhakar Y. (2014). Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol. Pak J Pharm Sci 27:115–20
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. (2006). Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press
   Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54
   PubMed Web of Science ®Google Scholar
• Samyuktha Rani B, Vedha Hari BN. (2011). Niosomal formulation of orlistat: formulation and in-vitro evaluation. Int J Drug Dev Res 3:300–11
   Google Scholar
• Satturwar PM, Fulzele SV, Nande VS, Khandare JN. (2002). Formulation and evaluation of ketoconazole niosomes. Indian J Pharm 64:155–8
   Google Scholar
• Shargel L, Wu-Pong S, Yu ABC. (2005). Applied biopharmaceutics & pharmacokinetics. New York: Appleton & Lange Reviews/McGraw-Hill, Medical Pub, 457
   Google Scholar
• Shatalebi MA, Mostafavi SA, Moghaddas A. (2010). Niosome as a drug carrier for topical delivery of N-acetyl glucosamine. Res Pharm Sci 5:107–17
   PubMedGoogle Scholar
• Singla S, Hari Kumar SL, Aggarwal G. (2012). Proniosomes for penetration enhancement in transdermal system. Int J Drug Dev Res 4:1–13
   Google Scholar
• Soliman SMH, Abd El-Malak NS, El-Gazayerly ON, Abd El-Rehim AEA. (2010). Formulation of microemulsion gel systems for transdermal delivery of celecoxib: in-vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther 4:459–71
   PubMedGoogle Scholar
• Soliman SMH, Abd El-Malak NS, El-Gazayerly ON, Abd El-Rehim AEA. (2011). Preparation of celecoxib solid dispersions for dermal application: in vitro characterization and skin irritation test. J Drug Del Sci Tech 21:509–16
   Web of Science ®Google Scholar
• Szuts A, Makai Z, Rajko R, Szabo-Revesz P. (2008). Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release. J Pharm Biomed Anal 48:1136–42
   PubMed Web of Science ®Google Scholar
• Thomas L, Viswanad V. (2012). Formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design. J Sci Pharm 80:731–48
   PubMedGoogle Scholar
• Ustundag ON, Apaydin S, Karabay YNU, et al. (2011). Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm 416:136–44
   PubMed Web of Science ®Google Scholar
• Vora B, Khopade AJ, Jain NK. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54:149–65
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, et al. (2013). Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm 456:446–58
   PubMed Web of Science ®Google Scholar
• Wang Y, Tu S, Li R, et al. (2010). Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior. Nanomed: Nanotechnol Biol Med 6:471–7
   PubMed Web of Science ®Google Scholar
• Xu H, He L, Nie S, et al. (2009). Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release 140:61–8
   PubMed Web of Science ®Google Scholar
• Yadav K, Yadav D, Saroha K, et al. (2010). Proniosomal gel: a provesicular approach for transdermal drug delivery. Der Pharm Lett 2:189–98
   Google Scholar
• Yasam VR, Jakki SL, Natarajan J, Kuppusamy G. (2014). A review on novel vesicular drug delivery: proniosomes. Drug Deliv 21:243–9
   PubMed Web of Science ®Google Scholar